SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : CHTL - Things Dreams Are Made Of..... -- Ignore unavailable to you. Want to Upgrade?

To: erik vilnis who wrote (278)11/25/1997 5:57:00 PM
From: Norrin Radd  Read Replies (1) | Respond to of 746
 
Erik, that article is an example of why I think the word about Ethocyn will get around. And if folks see that it works, the price of Ethocyn is no object. Witness the "half face" users of Ethocyn.

In the meantime it will be interesting to see what happens here.



To: erik vilnis who wrote (278)11/30/1997 1:25:00 PM
From: J R KARY  Respond to of 746
 
Hi Erik: Chantal's falling stock price indicates a company problem

Must admire the blind faith shown here for Chantal but there are more worthy skin-care opportunities .

Read Alpha Hydrox's site : alpha-hydrox.com

SGD has more than just AHA skin-care products making for a solid investment opportunity in a established , well run company .

SGD's 1997 performance is not priced in its stock price YET !

Hope this helps and my best all . Jim K.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News